Trials / Unknown
UnknownNCT04180501
SRS Sequential Sindilimab in Brain Metastasis of NSLSC
A Phase II Study on the Treatment of Advanced Non-small Cell Lung Cancer With Brain Metastasis by SRS Sequential Sintilimab
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- Xiaorong Dong · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
A phase II study on the treatment of advanced non-small cell lung cancer with brain metastasis by SRS sequential sintilimab
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | SRS sequential sintilimab | The subjects first received a targeted radiotherapy of SRS, and started the treatment of sintilimab per 3 weeks within 35 days after SRS. |
Timeline
- Start date
- 2019-11-01
- Primary completion
- 2021-09-01
- Completion
- 2021-12-01
- First posted
- 2019-11-27
- Last updated
- 2019-11-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04180501. Inclusion in this directory is not an endorsement.